OncoTherapy Science Inc (4564):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:OncoTherapy Science Inc (4564) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3493
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and development activities to develop its anti-cancer drug by providing technology platforms that include laser micro-beam microdissection, cDNA microarray and identification of target genes. The company partners with other healthcare industries to test and develop vaccines for increasing the efficiency of treating cancer. It holds interest in genome analysis of liquid biopsy, cancer and immunotherapy including development of neoantigen prediction. OncoTherapy is headquartered in Kawasaki, Japan.

OncoTherapy Science Inc (4564) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OncoTherapy Science Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OncoTherapy Science Inc, Medical Devices Deals, 2012 to YTD 2018 9
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
OncoTherapy Science to Enter into Collaboration Agreement with Osaka Cancer Immuno-Chemotherapy Clinic, Fukuoka General Cancer Clinic, Biothera Clinic 11
OncoTherapy Science and Theragen Etex to Form Joint Venture 12
OncoTherapy Science and Tella Enter into Co-Development Agreement 13
OncoTherapy Science Enters Into Co-Development Agreement With Acronet 14
Licensing Agreements 15
Shionogi Enters Into Licensing Agreement With OncoTherapy Science For Cancer Peptide Vaccines 15
Equity Offering 16
OncoTherapy Science Prices Private Placement Of Shares For US$12.7 Million 16
OncoTherapy Science Inc – Key Competitors 17
OncoTherapy Science Inc – Key Employees 18
OncoTherapy Science Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Recent Developments 20
Product News 20
Aug 08, 2018: OncoTherapy: Publication of a paper on the development of small molecule compounds inhibiting a novel anti-cancer drug target 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OncoTherapy Science Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OncoTherapy Science Inc, Deals By Therapy Area, 2012 to YTD 2018 8
OncoTherapy Science Inc, Medical Devices Deals, 2012 to YTD 2018 9
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OncoTherapy Science to Enter into Collaboration Agreement with Osaka Cancer Immuno-Chemotherapy Clinic, Fukuoka General Cancer Clinic, Biothera Clinic 11
OncoTherapy Science and Theragen Etex to Form Joint Venture 12
OncoTherapy Science and Tella Enter into Co-Development Agreement 13
OncoTherapy Science Enters Into Co-Development Agreement With Acronet 14
Shionogi Enters Into Licensing Agreement With OncoTherapy Science For Cancer Peptide Vaccines 15
OncoTherapy Science Prices Private Placement Of Shares For US$12.7 Million 16
OncoTherapy Science Inc, Key Competitors 17
OncoTherapy Science Inc, Key Employees 18
OncoTherapy Science Inc, Subsidiaries 19
OncoTherapy Science Inc, Joint Venture 19

List of Figures
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OncoTherapy Science Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[OncoTherapy Science Inc (4564):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PharmAust Ltd (PAA)-製薬・医療分野:企業M&A・提携分析
    Summary PharmAust Ltd (PharmAust) is a drug discovery and development company which provides human and veterinary proprietary medicines to treat different types of cancers. The company provides specialized medicinal and synthetic chemistry services. It specializes in bio defense and laboratory suppo …
  • HORNBACH Holding AG & Co. KGaA:企業の戦略・SWOT・財務情報
    HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ostfold Energi AS:企業の戦略的SWOT分析
    Ostfold Energi AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Godrej Consumer Products Limited:企業のM&A・事業提携・投資動向
    Godrej Consumer Products Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Godrej Consumer Products Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Air Liquide Welding France, S.A.:企業の戦略・SWOT・財務情報
    Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report Summary Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Nuvia Ltd:企業の戦略的SWOT分析
    Nuvia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Consolidated Edison Company of New York Inc:企業の発電所・SWOT分析2018
    Consolidated Edison Company of New York Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, info …
  • KfW Group:企業の戦略・SWOT・財務分析
    KfW Group - Strategy, SWOT and Corporate Finance Report Summary KfW Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Traverse Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Traverse Biosciences Inc (Traverse Biosciences) is an privately held bioscience company that commercializes drug candidates for the treatment of inflammatory diseases and age-related conditions affecting humans and companion animals. The company provides lead candidate TRB-N0224 which is dev …
  • Celon Pharma SA (CLN)-製薬・医療分野:企業M&A・提携分析
    Summary Celon Pharma SA (Celon Pharma) is an integrated pharmaceutical company which carries out research and develops novel therapies. Its product portfolio includes Aromek, Salmex, Valzek, Lazivir, Bosentan Celon, Donepex and Ketrel. The company primarily focuses on the development of pharmaceutic …
  • Harvard Stem Cell Institute-製薬・医療分野:企業M&A・提携分析
    Summary Harvard Stem Cell Institute (HSCI), a subsidiary of Harvard University is a healthcare institute that conducts research on advance stem cell science using stem cell biology to develop new treatments and cures for disease. The institute provides research programs such as disease programs, cor …
  • Monster Beverage Corporation:企業の戦略・SWOT・財務情報
    Monster Beverage Corporation - Strategy, SWOT and Corporate Finance Report Summary Monster Beverage Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Mitsubishi Electric Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Electric Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Electric Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Honeywell International Inc (HON):石油・ガス:M&Aディール及び事業提携情報
    Summary Honeywell International Inc. (Honeywell) is a diversified manufacturing and technology company. The company offers avionics, aircraft engines, systems and service solutions; environmental and combustion controls, sensing controls, security and life safety products and services, scanning and …
  • CJ O Shopping Co.,Ltd (035760):企業の財務・戦略的SWOT分析
    CJ O Shopping Co.,Ltd (035760) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Blue Star Ltd (BLUESTARCO):企業の財務・戦略的SWOT分析
    Summary Blue Star Ltd (BSL) is an air conditioning and commercial refrigeration company that manufactures cooling products. The company’s products include room air conditioners, air purifiers, water purifiers, air coolers, water coolers, cold storages and specialty products. It also offers deep free …
  • Franz Haniel & Cie. GmbH:企業の戦略的SWOT分析
    Franz Haniel & Cie. GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Alfa SAB de CV (ALFAA):企業の財務・戦略的SWOT分析
    Alfa SAB de CV (ALFAA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Sinclair Oil Corp:企業の戦略的SWOT分析
    Sinclair Oil Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Procurri Corporation Limited (BVQ):企業の財務・戦略的SWOT分析
    Procurri Corporation Limited (BVQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆